openPR Logo
Press release

Pharmacy OneSource Announces Free Webinar on Stroke Prevention in Atrial Fibrillation

02-25-2011 09:09 AM CET | Health & Medicine

Press release from: Pharmacy OneSource

Examining antithrombotic agents and developing patient-specific treatment plans

Bellevue, Wash. – Wolters Kluwer Health announced today that Pharmacy OneSource, software-as-a-service provider of Sentri7, a real-time clinical surveillance, documentation and reporting system, is hosting a complimentary webinar with Ann Wittkowsky, Pharm.D., CACP, FASHP, FCCP, on "Stroke Prevention in Atrial Fibrillation."

In this webinar, Wittkowsky will review epidemiology, pathophysiology and risk factors for stroke in patients with atrial fibrillation (AF). She will evaluate the role of traditional and new antithrombotic agents for stroke prevention in AF. Finally, she will examine development and management of patient-specific treatment plans for stroke prevention in AF.

Stroke Prevention in Atrial Fibrillation
DATE: Wednesday, March 2, 2011
TIME: 12:00 PM - 1:00 PM EST
WHERE: http://www.pharmacyonesource.com/webinars

About the Presenter: Ann K. Wittkowsky, Pharm.D., CACP, FASHP, FCCP, is Clinical Professor of Pharmacy at the University of Washington School of Pharmacy and Director of Anticoagulation Services at the University of Washington Medical Center. As a clinician and educator in the field of antithrombotic pharmacotherapy, she has contributed extensively to the care of patients and the education of health care providers regarding antithrombotic pharmacotherapy. She is the author of over 100 scientific papers, book chapters and abstracts, and co-editor of the textbook Managing Oral Anticoagulation Therapy: Clinical and Operational Guidelines. She has lectured widely throughout the United States and Canada, maintains an active clinical research program, and is board certified as an anticoagulation care provider.

About Pharmacy OneSource
Pharmacy OneSource is healthcare’s #1 Software-as-a-Service (SaaS) provider. Our more than 100 innovative team members provide best-in-class, SaaS solutions to current and future challenges within health-systems worldwide. Our SaaS solutions contribute to swift and safe healthcare through earlier, easier and better access to data. More than 1,300 healthcare organizations worldwide utilize our HIPAA compliant web-based services.

Pharmacy OneSource is part of Wolters Kluwer Health (Philadelphia, PA), a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools, journals, and textbooks, such as Lippincott Williams & Wilkins; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span®, Facts & Comparisons® and ProVation® Medical.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company focused on professionals with annual revenues (2009) of €3.4 billion ($4.8 billion), approximately 19,300 employees worldwide and operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Visit our website, YouTube or follow @Wolters_Kluwer on Twitter for more information about our market positions, customers, brands, and organization.

Pharmacy OneSource
3535 Factoria Blvd. SE #440
Bellevue, WA 98006

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacy OneSource Announces Free Webinar on Stroke Prevention in Atrial Fibrillation here

News-ID: 163979 • Views:

More Releases from Pharmacy OneSource

Richie's Specialty Pharmacy Selects Simplifi 797 for USP 797 Compliance
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Richie's Specialty Pharmacy, LLC has selected its Simplifi 797 software for achieving sterile compounding compliance. Simplifi 797 is a web-based application that automates, integrates and streamlines quality activities and documentation related to U.S. Pharmacopeia's Chapter 797 guidelines. The software manages task scheduling for environmental monitoring and automates the reporting of exceptions and compliance. "Simplifi
Pharmacy OneSource® Partners with CriticalPoint™ to Offer the Next Generation …
Bellevue, Washington – Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Pharmacy OneSource® has released a new version of Simplifi 797®, a web-based quality assurance software for USP chapter 797 compounding compliance. The upgraded version of Simplifi 797 includes CriticalPoint's education program, which gives users unlimited access to 42 hours of ACPE-approved continuing education credits supporting compliance with USP Chapter . Lessons
Wolters Kluwer Health Unveils Integration between UpToDate and Sentri7
Bellevue, WA -- Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that UpToDate's clinical knowledge system has been integrated with Sentri7 surveillance software by Pharmacy OneSource. This partnership of evidence-based clinical information through UpToDate and clinical patient surveillance from Sentri7 offers healthcare providers actionable information at the point of care to make better decisions in directing patient care. UpToDate synthesizes the most recent medical

More Releases for Pharm

Fosfomycin Market to Witness Huge Growth by 2026 | Northeast Pharm, Ercros, Shin …
The Latest Released Fosfomycin market study has evaluated the future growth potential of Global Fosfomycin market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities
Clopidol Market updates, demand analysis, and expected growth forecast 2021-2027 …
Global “Clopidol” Market Size, Status, and Forecast 2021-2027. In-depth research accumulated to offer Latest insights about acute features of the global Clopidol market. This report provides a detailed overview of key factors in the Clopidol Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. The effect of the COVID-19 outbreak at the enterprise turned into completely assessed. Fully chance evaluation and enterprise recommendations
Paromomycin Market updates, demand analysis, and expected growth forecast 2021-2 …
The new study on the Global “Paromomycin Market” 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the Paromomycin industry. Because of the in-depth overview of the Global Paromomycin market, the recent papers allow investors, traders, and manufacturers to plan some innovative techniques, and meanwhile, align them with operational and commercial enterprise models. Additionally, the Paromomycin market report offers crucial facets at the
Clopidol Market updates, demand analysis and expected growth forecast 2021-2027 …
The “Clopidol” Market report mainly studies the size, recent trends, and development status of the Clopidol market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain, and competitive landscape. Technological innovation and advancement will further enhance the performance of the product, making it more broadly used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for
Perphenazine Market Overall Study Report 2020-2027 | Players Sandoz, Actavis, Qu …
The latest report added by Stratagem Market Insights gives deep insights into the drivers and restraints in the Worldwide Perphenazine Market. The research report "Global Perphenazine Market Size and Growth Forecast to 2027" provide a comprehensive take on the overall market. Analysts have carefully evaluated the milestones achieved by the global Perphenazine market and the current trends that are likely to shape its future. Primary and secondary research methodologies have
Global Polygeline Injection Market Forecast 2018-2025 Abbott, Shengtai Pharm, BB …
A detailed market study on "Global Polygeline Injection Market" examines the performance of the Polygeline Injection market. It encloses an in-depth Research of the Polygeline Injection market state and the competitive landscape globally. This report analyzes the potential of Polygeline Injection market in the present and the future prospects from various angles in detail. The Global Polygeline Injection Market 2018 report includes Polygeline Injection market Revenue, market Share, Polygeline Injection industry